New species add to the list of iPSC sources, including monkey and rat cells.
The list of cell types capable of reprogramming to iPSC continues to grow.
2009-2014
Fewer and different factors also work for iPSC generation New pluripotency factors, miRNAs, lineage specifiers, and small molecules can replace Yamanaka factors for reprogramming.
2008-Present 2014

Disease modeling and therapeutic insights
The ability to recapitulate disease phenotypes and correct them using patient-specific iPSCs reveals the power of hiPSCs for understanding the genetic basis of disease, insights into pathogenesis, and potential treatments.
2008-2013
Chemical and genetic manipulation improve reprogramming efficiency via targeting epigenetic regulation
2006-2007
2011-Present
Self-organization and organoids iPSCs exhibit a self-organizing ability to form organoids, such as optic cups, mini-brains, and mini-guts. There is tremendous potential for application of such organoids in disease modeling and drug screening.
2008-2010
Reprogramming technology inspires advances in direct reprogramming 
2009-Present
Reprogramming mechanisms revealed
Evidence supports elements of both stochastic and deterministic models of reprogramming. Single-cell technology and reprogramming roadmaps highlight key stages and barriers to iPSC generation, including MET and epigenetic regulation. 
Generation of iPSCs
